These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 567809)

  • 41. The location of the high- and low-affinity bilirubin-binding sites on serum albumin: ligand-competition analysis investigated by circular dichroism.
    Goncharova I; Orlov S; Urbanová M
    Biophys Chem; 2013; 180-181():55-65. PubMed ID: 23838624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of Merocyanine 540 with serum albumins: photophysical and binding studies.
    Banerjee M; Pal U; Subudhhi A; Chakrabarti A; Basu S
    J Photochem Photobiol B; 2012 Mar; 108():23-33. PubMed ID: 22264940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding and circular dichoism data on bilirubin-albumin in the presence of oleate and salicylate.
    Wooley PV; Hunter MJ
    Arch Biochem Biophys; 1970 Sep; 140(1):197-209. PubMed ID: 5466734
    [No Abstract]   [Full Text] [Related]  

  • 44. The binding of colchicine and its derivatives to bovine and human serum albumin and human plasma.
    Trnavská Z; Kuchar M; Rejholec V; Trnavský K
    Pharmacology; 1979; 18(3):123-7. PubMed ID: 572067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions of tuftsin with bovine serum albumin.
    Bhakuni V; Gupta CM
    FEBS Lett; 1986 Sep; 205(2):347-50. PubMed ID: 3743782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction studies of resistomycin from Streptomyces aurantiacus AAA5 with calf thymus DNA and bovine serum albumin.
    Vijayabharathi R; Sathyadevi P; Krishnamoorthy P; Senthilraja D; Brunthadevi P; Sathyabama S; Priyadarisini VB
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Apr; 89():294-300. PubMed ID: 22285949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformation inversion of bilirubin formed by reduction of the biliverdin-human serum albumin complex: evidence from circular dichroism.
    Trull FR; Ibars O; Lightner DA
    Arch Biochem Biophys; 1992 Nov; 298(2):710-4. PubMed ID: 1416999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential modulation in binding of ketoprofen to bovine serum albumin in the presence and absence of surfactants: spectroscopic and calorimetric insights.
    Misra PP; Kishore N
    Chem Biol Drug Des; 2013 Jul; 82(1):81-98. PubMed ID: 23517326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of human serum albumin with meloxicam: characterization of binding site.
    Trynda-Lemiesz L; Wiglusz K
    J Pharm Biomed Anal; 2010 Jun; 52(2):300-4. PubMed ID: 20089378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spectroscopic interaction of a coumarin derivative with bovine serum albumin.
    Sindhu R; Tiwari AK; Mishra LC; Husain MM
    Cancer Biother Radiopharm; 2012 Sep; 27(7):452-6. PubMed ID: 22947088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measurement of protein binding by ultracentrifugation.
    Matsushita Y; Moriguchi I
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2948-55. PubMed ID: 4085054
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction between pirenoxine and bovine serum albumin in aqueous solution.
    Liao Z; Yu X; Yao Q; Yi P
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Aug; 129():314-9. PubMed ID: 24747854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced optical activity following the binding of warfarin, indomethacin, 4-hydroxycoumarin and salicylic acid to human serum albumin.
    Perrin JH; Nelson DA
    Life Sci I; 1972 Mar; 11(6):277-83. PubMed ID: 4653203
    [No Abstract]   [Full Text] [Related]  

  • 57. Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein.
    Yeggoni DP; Manidhar DM; Suresh Reddy C; Subramanyam R
    J Biomol Struct Dyn; 2016 Sep; 34(9):2023-36. PubMed ID: 26440860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unraveling the energetics and mode of the recognition of antibiotics tetracycline and rolitetracycline by bovine serum albumin.
    Choudhary S; Kishore N
    Chem Biol Drug Des; 2012 Nov; 80(5):693-705. PubMed ID: 22846623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study on the interaction between Besifloxacin and bovine serum albumin by spectroscopic techniques.
    Yu X; Jiang B; Liao Z; Jiao Y; Yi P
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():116-21. PubMed ID: 25950636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.